Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma
- Study Title
- Efficacy/Safety Study of Nebulized IVX-0142, a Novel AntiFemale, Maleergic Drug, in Mild Female, Maleergic Asthma
- Teva Identifier
- IXR-201-04-142
- ClinicalTrials.gov Identifier
- NCT00232999
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Nebulized IVX-0142
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 60 Years
- Trial Duration
- 10/01/2005 - 01/01/2006
- Phase
- Phase 2
